Beatriz Helena TESS

Dr. Beatriz Helena TESS


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2014 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
JRJ. P. Rey‐López
J. P. Rey‐López
LRLeandro F. M. Rezende
Leandro F. M. Rezende
MPM. Pastor‐Valero
M. Pastor‐Valero
BTBeatriz Helena TESS
Beatriz Helena TESS

1 August 1998 in Pediatrics
Verified
Journal Article
Closed access
PDF file
MGMonica O. Granovsky
Monica O. Granovsky
HMHoward L. Minkoff
Howard L. Minkoff
BTBeatriz Helena TESS
Beatriz Helena TESS
DWDavid Waters
David Waters
AHAngelos Hatzakis
Angelos Hatzakis
JGJames J. Goedert
James J. Goedert
Objectives. To estimate the hepatitis C virus (HCV) vertical transmission rate, the effect of potential risk factors, and the pattern of HCV antibody response and viremia in HCV-infected infants. Study Design. The Mothers and Infants Cohort Study enrolled both human immunodeficiency virus (HIV)-seropositive and HIV-seronegative pregnant women at five obstetric clinics in New York City in a prospective cohort study between January 1986 and January 1991. HCV-infected mothers and their 122 offspring were followed-up for a minimum of 12 months for evidence of HCV infection as determined by persistent HCV antibodies or detection of HCV RNA by reverse transcription polymerase chain reaction. Comparisons among groups for categorical variables were performed using the Fisher9s exact test. Results. Seven (6%; 95% confidence interval, 2%-11%) of the 122 infants were HCV-infected. There was a tendency for increased risk of transmission with maternal viral and obstetrical factors, such as coinfection with HIV (7% vs 4%), high HIV viral load (13% vs 6%), HCV viremia (8% vs 3%), vaginal delivery (6% vs 0%), and female gender of offspring (8% vs 3%), although none of the associations reached statistical significance. After loss of maternal antibody, HCV antibody seroconversion occurred at a mean age of 26 months in 3 HIV-coinfected infants compared with 7 months of age in 4 HCV-infected HIV-uninfected infants. Serial samples showed that HCV RNA persisted in 6 infants for at least 18 to 54 months. Conclusions. Our study is in accordance with other studies that have shown low overall HCV vertical transmission risk and a trend toward higher risk with maternal risk factors such as HIV-coinfection or HCV viremia. A delay in infant HCV antibody response may be associated with HIV coinfection although larger studies are needed to confirm these findings.

26 March 1998 in AIDS
Verified
Journal Article
Closed access
BTBeatriz Helena TESS
Beatriz Helena TESS
LRLaura C. Rodrigues
Laura C. Rodrigues
MNMarie-Louise Newell
Marie-Louise Newell
DDDavid T. Dunn
David T. Dunn
TLTania D.G. Lago
Tania D.G. Lago
Objectives: To evaluate the effect of maternal, obstetric, neonatal and post-natal factors on the risk of vertical transmission of HIV-1. Design: Multicentre retrospective cohort study. Setting: Obstetric and paediatric clinics in four cities in Sao Paulo State, Brazil. Main outcome: Child's HIV-1 infection status. Methods: Data were collected by standardized record abstraction and interview on 553 children born to women identified as HIV-1-infected before or at delivery. Paediatric infection was determined by immunoglobulin G anti-HIV-1 tests at age 18 months or by AIDS diagnosis at any age. Multivariate logistic regression was used to assess the effect of potential risk factors on vertical transmission of HIV-1. Results: HIV-1 infection status was determined for 434 children (follow-up rate of 78%); 69 were classified as HIV-1-infected [transmission risk, 16%; 95% confidence interval (CI), 13–20%]. In multivariate analysis, advanced maternal HIV-1 disease [odds ratio (OR), 4.5; 95% CI, 2.1-9.5], ever breastfed (OR, 2.2; 95% CI, 1.2–4.2), child's negative Rhesus blood group (OR, 2.5; 95% CI, 1.2–5.5), third trimester amniocentesis (OR, 4.1; 95% CI, 1.2–13.5) and black racial group (OR, 0.3; 95% CI, 0.1–0.9) were independently and significantly associated with mother-to-child transmission of HIV-1. Transmission was increased marginally with prematurity, more than 10 lifetime sexual partners and prolonged duration of membrane rupture. No association was found between child's HIV-1 infection and mode of delivery or serological evidence of syphilis during pregnancy. Conclusion: These findings support the importance of severity of maternal HIV-1 disease in the risk of vertical transmission of HIV-1, indicate measures to reduce transmission by avoiding amniocentesis and breastfeeding and suggest that race and Rhesus blood type may be markers for genetic susceptibility to infection.

1 October 1998 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
BTBeatriz Helena TESS
Beatriz Helena TESS
LRLaura C. Rodrigues
Laura C. Rodrigues
MNMarie-Louise Newell
Marie-Louise Newell
DDDavid T. Dunn
David T. Dunn
TLTania D. G. Lago
Tania D. G. Lago
Although vertical transmission of HIV-1 can occur through breast-feeding, little is known about the effect of colostrum, duration of breast-feeding, mixing feeding, and nipple pathology. We used retrospective cohort data to examine the association between breast-feeding-related factors and transmission of HIV-1 from mother to child in São Paulo State, Brazil. Information on maternal and postnatal factors was collected by medical record review and interview. Infection status was determined for 434 children by anti-HIV-1 tests performed beyond 18 months of age or diagnosis of AIDS at any age. Among 168 breast-fed children, the risk of transmission of HIV-1 was 21%, compared with 13% (p = .01) among 264 children artificially fed. Breast-feeding was independently and significantly associated with mother-to-child transmission of HIV-1 after controlling for stage of maternal HIV-1 disease (odds ratio [OR] = 2.2; 95% confidence interval [CI], 1.3-3.8). A trend was shown toward an increased risk of transmission with longer duration of breast-feeding, a history of bleeding nipples, and introduction of other liquid food before weaning, but these associations were not statistically significant. History of colostrum intake or cracked nipples without bleeding were not associated with transmission. Most of the women who breast-fed were unaware of their HIV-1 infection status at the time of delivery. Avoidance of mixed feeding and withholding of breast-feeding in the presence of bleeding nipples should be considered in further research as strategies to reduce postnatal transmission of HIV-1 in settings in which safe and sustainable alternatives for breast-feeding are not yet available.

1 June 2002 in Blood
Verified
Journal Article
Closed access
PDF file
CRCharles S. Rabkin
Charles S. Rabkin
BTBeatriz Helena TESS
Beatriz Helena TESS
RCRoberta E. Christianson
Roberta E. Christianson
WWWilliam E. Wright
William E. Wright
DWDavid J. Waters
David J. Waters
BBBea J. van Den Berg
Bea J. van Den Berg
Several case-control studies have found increased prevalence of hepatitis C virus (HCV) in patients with non-Hodgkin lymphoma (NHL) and other B-cell lymphoproliferative disorders. We examined whether HCV infection preceded the development of these neoplasms in a prospective cohort study of 48 420 individuals in northern California. Stored sera from 95 subjects with NHL (n = 57), multiple myeloma (n = 24), or Hodgkin disease (n = 14) diagnosed a mean of 21 years after phlebotomy were screened for antibodies to HCV as well as viral RNA, based on previous reports of antibody-negative viremia. Sera from 4 cases and one of 95 age-, sex-, and race-matched controls were repeatedly reactive by enzyme immunoassay, but none were confirmed by recombinant immunoblot assay; none of the case sera had HCV RNA by reverse transcription– polymerase chain reaction. Although acquisition in later life cannot be ruled out, these prospective data do not support a substantial role of chronic HCV infection in the etiology of B-cell neoplasia.

1 February 1993 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
BTBeatriz Helena TESS
Beatriz Helena TESS
HGH. M. Glenister
H. M. Glenister
LRL. C. Rodrigues
L. C. Rodrigues
MWM. B. Wagner
M. B. Wagner